Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.74
BATS BZX Real-Time Price
As of 11:52am ET
 -0.10 / -0.24%
Today’s Change
37.20
Today|||52-Week Range
44.54
+5.79%
Year-to-Date

Today’s Trading

Previous close40.84
Today’s open40.69
Day’s range40.62 - 40.84
Volume136,418
Average volume (3 months)3,020,885
Market cap$100.4B
Dividend yield4.97%
Data as of 11:52am ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.87%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+2.85%
P/E ratio51.7
Price/Sales2.52
Price/Book71.56

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.03+0.05%
NVONovo Nordisk-0.28-0.55%
LLYEli Lilly and Co+0.31+0.36%
CELGCelgene+1.19+0.98%
Data as of 11:55am ET, 10/23/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.83
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts